MedTrace Logo

Calcific Tendonitis Treatment: Barbotage vs. Barbotage With Cortisone Injection

NCT04126278 · Status: TERMINATED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 4

Last updated 2024-01-05

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine the efficacy of barbotage therapy by comparing the clinical and sonographic changes in patients that solely receive barbotage to patients receiving the standard of care, barbotage with cortisone injection.

Conditions

  • Calcific Tendinitis

Interventions

DRUG

Barbotage

Administered as per standard of care

DRUG

Dexamethasone

4 mg of dexamethasone

Sponsors & Collaborators

Principal Investigators

  • Mehul Shah · NYU Langone

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-12-01
Primary Completion
2022-08-12
Completion
2022-08-23
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04126278 on ClinicalTrials.gov